CD25+CD4+ regulatory T cells in patients with Kawasaki disease
- PMID: 15343196
- DOI: 10.1016/j.jpeds.2004.05.048
CD25+CD4+ regulatory T cells in patients with Kawasaki disease
Abstract
Objective: To investigate whether the CD25 + CD4 + regulatory T-cell population, which plays important roles not only in maintaining immunologic self-tolerance but also in controlling the magnitude and character of antimicrobial immune responses, is related to the pathophysiology of Kawasaki disease (KD).
Study design: The patient group consisted of 54 patients (median age, 30 months; 27 female and 27 male patients) fulfilling the criteria for KD. Age-matched control subjects included 17 patients with active infections and 24 healthy children. We analyzed CD25 + CD4 + cells and the mRNA expression of Foxp3, cytotoxic T lymphocyte-associated antigen 4 (CTLA4), glucocorticoid-induced tumor necrosis factor receptor (GITR), and transforming growth factor beta in peripheral blood mononuclear cells and purified CD4 + T cells.
Results: The proportions of CD25 + CD4 + cells in patients with acute-phase KD (median, 2.35% of total lymphocytes) were significantly lower than those in healthy control subjects (median, 3.14%) and control subjects with disease (median, 3.15%). The proportions returned to the normal level after intravenous gammaglobulin treatment (median, 3.86%). The mRNA expression of Foxp3, CTLA4, and GITR showed similar tendencies.
Conclusions: The decrease of CD25 + CD4 + regulatory T cells in the acute phase might have a role in the development of KD.
Similar articles
-
CD4+CD25+ regulatory T lymphocytes in malignant pleural effusion.Am J Respir Crit Care Med. 2005 Dec 1;172(11):1434-9. doi: 10.1164/rccm.200504-588OC. Epub 2005 Sep 8. Am J Respir Crit Care Med. 2005. PMID: 16151041
-
Induction of eye-derived tolerance does not depend on naturally occurring CD4+CD25+ T regulatory cells.Invest Ophthalmol Vis Sci. 2006 Mar;47(3):1047-55. doi: 10.1167/iovs.05-0110. Invest Ophthalmol Vis Sci. 2006. PMID: 16505040
-
Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers.Clin Cancer Res. 2003 Oct 1;9(12):4404-8. Clin Cancer Res. 2003. PMID: 14555512
-
Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.Cancer Res. 2001 Jun 15;61(12):4766-72. Cancer Res. 2001. PMID: 11406550
-
Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus.Immunology. 2006 Feb;117(2):280-6. doi: 10.1111/j.1365-2567.2005.02306.x. Immunology. 2006. PMID: 16423064 Free PMC article.
Cited by
-
The CXCL10/CXCR3 Axis and Cardiac Inflammation: Implications for Immunotherapy to Treat Infectious and Noninfectious Diseases of the Heart.J Immunol Res. 2016;2016:4396368. doi: 10.1155/2016/4396368. Epub 2016 Oct 3. J Immunol Res. 2016. PMID: 27795961 Free PMC article. Review.
-
BTNL2 gene polymorphisms may be associated with susceptibility to Kawasaki disease and formation of coronary artery lesions in Taiwanese children.Eur J Pediatr. 2010 Jun;169(6):713-9. doi: 10.1007/s00431-009-1099-5. Epub 2009 Nov 1. Eur J Pediatr. 2010. PMID: 19882345
-
The T helper type 17/regulatory T cell imbalance in patients with acute Kawasaki disease.Clin Exp Immunol. 2010 Oct;162(1):131-7. doi: 10.1111/j.1365-2249.2010.04236.x. Epub 2010 Aug 16. Clin Exp Immunol. 2010. PMID: 20718783 Free PMC article.
-
The CXCL10-CXCR3 axis plays an important role in Kawasaki disease.Clin Exp Immunol. 2024 Mar 12;216(1):104-111. doi: 10.1093/cei/uxad125. Clin Exp Immunol. 2024. PMID: 37952216 Free PMC article.
-
Regulatory T cells in cardiovascular diseases.Nat Rev Cardiol. 2016 Mar;13(3):167-79. doi: 10.1038/nrcardio.2015.169. Epub 2015 Nov 3. Nat Rev Cardiol. 2016. PMID: 26525543 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials